These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 275533)

  • 21. Loss of terminal deoxynucleotidyl transferase (TdT) activity as a predictor of emergence of resistance to chemotherapy in a case of chronic myelogenous leukemia in blast crisis.
    Ross DD; Wiernik PH; Sarin PS; Whang-Peng J
    Cancer; 1979 Nov; 44(5):1566-70. PubMed ID: 291471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Terminal deoxynucleotidyl transferase as a biological marker for human leukemia.
    Sarin PS; Gallo RC
    Hamatol Bluttransfus; 1976; 19():491-502. PubMed ID: 13027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Terminal deoxynucleotidyl transferase in acute leukemias by direct immunofluorescence.
    Nair CN; Gothoskar BP; Gladstone B; Badrinath Y; Chhajlani V; Karnik M; Nerurkar A; Damle SR; Redkar SL; Gopal R
    Neoplasma; 1987; 34(3):305-11. PubMed ID: 3302737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosomal abnormalities in lymphoid crisis of chronic myelogenous leukemia.
    Yao E
    Cancer Genet Cytogenet; 1985 Apr; 16(3):235-43. PubMed ID: 3856469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Philadelphia chromosome-positive chronic myelogenous leukemia following apparent acute lymphoblastic leukemia.
    Hajjar KA
    Clin Pediatr (Phila); 1985 Jul; 24(7):402-5. PubMed ID: 3859395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphoid blastic crisis at the onset of chronic granulocytic leukemia: report of two cases.
    Mauri C; Torelli U; di Prisco U; Silingardi V; Artusi T; Emila G
    Cancer; 1977 Aug; 40(2):865-70. PubMed ID: 268231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical and immunological properties of human terminal deoxynucleotidyl transferase purified from blasts of acute lymphoblastic and chronic myelogenous leukemia.
    Deibel MR; Coleman MS; Acree K; Hutton JJ
    J Clin Invest; 1981 Mar; 67(3):725-34. PubMed ID: 6937474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Terminal deoxynucleotidyl transferase in the blastic phase of chronic myelogenous leukemia: an indicator of response to vincristine and prednisone therapy.
    Tanaka M; Kaneda T; Hirota Y; Yoshida S; Kitajima K
    Am J Hematol; 1980; 9(3):287-93. PubMed ID: 6940442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Philadelphia chromosome-positive chronic myeloid leukemia with washing out of Ph'-negative lymphoid blasts and with meningiosis: atypical blast crisis or a 2d leukemia?].
    Merlin D; Auf der Maur P; Kappeler R
    Schweiz Med Wochenschr; 1984 Mar; 114(9):303-8. PubMed ID: 6584970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous evaluation for terminal deoxynucleotidyl transferase and myeloperoxidase in leukemia.
    Folds JD; Bollum FJ; Dean L; Chan J; Stass SA
    Am J Hematol; 1982 Jun; 12(4):391-6. PubMed ID: 6287839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Karyotype in chronic myeloid leukemia in a blastic crisis. II. Trisomy 17].
    Geraci L; Palka G; Felaco M; Miscia S; D'Antuono A; Caramelli E
    Boll Soc Ital Biol Sper; 1981 Jan; 57(2):149-51. PubMed ID: 6940606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histochemical demonstration of terminal deoxynucleotidyl transferase in leukemia.
    Hecht T; Forman SJ; Winkler US; Santos S; Winkler KJ; Carlson F; Maslow WC; Borer WZ; Blume KG
    Blood; 1981 Oct; 58(4):856-8. PubMed ID: 7023572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis.
    Derderian PM; Kantarjian HM; Talpaz M; O'Brien S; Cork A; Estey E; Pierce S; Keating M
    Am J Med; 1993 Jan; 94(1):69-74. PubMed ID: 8420302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous evaluation of terminal deoxynucleotidyl transferase and myeloperoxidase in acute leukemias using an immunocytochemical method.
    Kaplan SS; Penchansky L; Krause JR; Basford RE; Zdziarski U
    Am J Clin Pathol; 1987 Jun; 87(6):732-8. PubMed ID: 3035914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different kinetic pattern of chronic myeloid leukemia: lymphoblastic and myeloblastic blastic crisis.
    Piacibello W; Aglietta M; Gavosto F
    Tumori; 1980 Jun; 66(3):295-303. PubMed ID: 6934637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukemia with multiple phenotypic expressions.
    Kaplan SS; Krause JR; Srodes CH
    Am J Clin Pathol; 1984 Aug; 82(2):232-5. PubMed ID: 6589954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High terminal deoxynucleotidyl transferase activity in acute myelogenous leukemia.
    Sahai Srivastava BI; Khan SA; Henderson ES
    Cancer Res; 1976 Oct; 36(10):3847-50. PubMed ID: 1085195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enrichment of cell populations containing terminal deoxynucleotidyl transferase activity by free flow electrophoresis.
    Sarin PS; Virmani M; Gallo RC
    Int J Cancer; 1982 May; 29(5):501-6. PubMed ID: 6954135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase I-II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia.
    Koller CA; Kantarjian HM; Feldman EJ; O'Brien S; Rios MB; Estey E; Keating M
    Cancer; 1999 Dec; 86(11):2246-51. PubMed ID: 10590364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
    Han T; Gomez GA; Minowada J
    Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.